MedMen / Ascend dispute escalates
MSO Ascend Wellness Holdings claimed MSO MedMen had challenged the authority of New York regulators. The accusation comes after MedMen announced, earlier this week, that it would terminate a deal to be sell more than 86% of its New York business to Ascend for $73M.
- Ascend alleges MedMen is backing out of the deal on grounds that it was not cleared by New York state regulators. Ascend says state regulators . . .
Log in or become a WeedWeek Member to read this article.
